XML 26 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net loss $ (52,527) $ (57,457) $ (71,728)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 77 232 284
Change in fair value of derivative liability 4,899 7,117 (2,782)
Change in fair value of warrant liability     300
Loss on extinguishment of debt 86   22,700
Amortization of debt discount 151 240 3,006
Non-cash interest expense 260 351 1,731
Share-based compensation 4,179 4,224 3,244
Loss on disposal of asset   43  
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets (440) (622) 1,214
Accounts payable (59) (6,140) (1,503)
Accrued expenses, accrued interest payable and other current liabilities (1,497) (1,527) (4,450)
Other assets (100)    
Net cash used in operating activities (44,971) (53,539) (47,984)
Cash flows from investing activities:      
Purchase of property and equipment (67) (35) (130)
Payment for security deposit 250 (25)  
Net cash used in investing activities 183 (60) (130)
Cash flows from financing activities:      
Proceeds from issuance of convertible notes payable     5,000
Proceeds from venture debt issuance, net of costs 14,805    
Proceeds from issuance of ordinary shares, net of commissions and underwriters' fees 8,975 23,437 8,913
Proceeds from development funding agreement 45,000 20,000  
Proceeds from issuance from the IPO, net of commissions     79,105
Payment of debt issuance costs (125)   (85)
Payment of offering costs (408) (337) (2,151)
Principal payments on term debt (9,111) (7,482) (2,805)
Proceeds from exercise of share options and warrant     50
Net cash provided by financing activities 59,136 35,618 88,027
Net increase (decrease) in cash and cash equivalents 14,348 (17,981) 39,913
Cash and cash equivalents, beginning of period 32,787 50,768 10,855
Cash and cash equivalents, end of period 47,135 32,787 50,768
Supplemental disclosure of noncash investing and financing activity:      
Commitment shares issued to Lincoln Park   368  
Issuance cost in accounts payable 58 147  
Fair value of derivatives recorded in connection with the 2018 MVIL Note and 2018 New Investor Notes     1,256
Conversion of convertible preferred shares into ordinary shares     211,377
Conversion of convertible notes and accrued interest into ordinary shares     175,210
Reclassification of deferred offering cost to additional paid-in capital 251   447
Reclassification of Future Warrants to equity 4,017 1,962  
Reclassification of warrant liability to equity     400
Supplemental cash flow information-cash paid for end of term charge 1,661    
Supplemental cash flow information-cash paid for interest $ 905 $ 1,195 $ 1,918